Daniel Karlin
Chief Medical Officer, Director at Definium Therapeutics, Inc. (DFTX) since January 2022
Daniel Karlin has filed 36 insider reports with the SEC since January 2022, as chief Medical Officer and director at Definium Therapeutics, Inc. (DFTX) and officer at Mind Medicine (MindMed) Inc. (MNMD). In the last 12 months Daniel Karlin sold $1.07M of stock on the open market. In the latest filing, on September 30, 2026, Daniel Karlin sold 10,853 shares of Definium Therapeutics, Inc. (DFTX) for $397K at an average of $36.57.
- Filings
- 36
- Companies
- 2
- Bought on market
- None
- Sold on market
- $1.6M
Companies where Daniel Karlin is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officer, Directorsince January 2022 | 792,846 | $1.6M | $29.48 | Sep 30, 2026 | |||
| Officer | Dec 26, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 25, 2026-$397KDFTXChief Medical Officer Karlin Daniel sold $396,894 worth of shares (10,853 units at $36.57) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 792,846 units (withholding obligation)Form 4Open-market sale10b5-1 plan
- Sep 14, 2026DFTXChief Medical Officer Karlin Daniel was granted 200,000 shares, increasing direct ownership by 33% to 803,699 unitsForm 4Grant or award
- Aug 12, 2026DFTXChief Medical Officer Karlin Daniel was granted 100,000 shares, increasing direct ownership by 20% to 603,282 unitsForm 4Grant or award
- Jun 25, 2026-$452KDFTXChief Medical Officer Karlin Daniel sold $451,876 worth of shares (10,035 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 503,282 units (withholding obligation)Form 4Open-market sale10b5-1 plan
- Jun 22, 2026DFTXChief Medical Officer Karlin Daniel was granted 100,000 shares, increasing direct ownership by 24% to 513,317 unitsForm 4Grant or award
- Mar 25, 2026-$148KDFTXSEC Form 4 filed by Karlin DanielForm 4Open-market sale10b5-1 plan
- Feb 3, 2026DFTXChief Medical Officer Karlin Daniel was granted 150,000 shares, increasing direct ownership by 35% to 575,025 unitsForm 4Grant or award
- Dec 26, 2025-$73.6KDFTXChief Medical Officer Karlin Daniel sold $73,623 worth of shares (5,600 units at $13.15), decreasing direct ownership by 1% to 425,025 unitsForm 4Open-market sale10b5-1 plan
- Sep 25, 2025-$75.3KDFTXChief Medical Officer Karlin Daniel sold $75,268 worth of shares (7,704 units at $9.77), decreasing direct ownership by 2% to 430,625 unitsForm 4Open-market sale10b5-1 plan
- Jun 25, 2025-$53.4KDFTXChief Medical Officer Karlin Daniel sold $53,366 worth of shares (7,848 units at $6.80), decreasing direct ownership by 2% to 438,329 unitsForm 4Open-market sale10b5-1 plan
- Mar 25, 2025-$46.1KDFTXChief Medical Officer Karlin Daniel sold $46,075 worth of shares (6,836 units at $6.74), decreasing direct ownership by 2% to 446,177 unitsForm 4Open-market sale10b5-1 plan
- Mar 12, 2025DFTXChief Medical Officer Karlin Daniel was granted 115,000 shares, increasing direct ownership by 34% to 453,013 unitsForm 4Grant or award
- Dec 26, 2024-$49.4KDFTXChief Medical Officer Karlin Dan sold $49,357 worth of shares (6,643 units at $7.43), decreasing direct ownership by 2% to 338,013 unitsForm 4Open-market sale10b5-1 plan
- Sep 25, 2024-$41.1KDFTXChief Medical Officer Karlin Dan sold $41,089 worth of shares (6,871 units at $5.98), decreasing direct ownership by 2% to 344,656 unitsForm 4Open-market sale10b5-1 plan
- Jun 25, 2024-$50KDFTXChief Medical Officer Karlin Dan sold $49,998 worth of shares (6,925 units at $7.22), decreasing direct ownership by 2% to 351,527 unitsForm 4Open-market sale10b5-1 plan
- Mar 25, 2024-$62.5KDFTXKarlin Dan sold $62,491 worth of shares (6,578 units at $9.50), decreasing direct ownership by 2% to 358,452 unitsForm 4Open-market sale10b5-1 plan
- Feb 27, 2024DFTXSEC Form 4 filed by Karlin DanForm 4Grant or award
- Dec 26, 2023-$24.6KDFTXKarlin Dan sold $24,590 worth of shares (6,774 units at $3.63), decreasing direct ownership by 2% to 365,030 unitsForm 4Open-market sale
- Dec 26, 2023~$24.6KMNMDDaniel Karlin plans to sell 6,774 shares (~$24.6K)Form 144Planned sale10b5-1 plan
- Sep 25, 2023-$24.7KDFTXKarlin Dan sold $24,730 worth of shares (6,918 units at $3.57), decreasing direct ownership by 2% to 371,804 unitsForm 4Open-market sale
- Jun 27, 2023-$21.7KDFTXSEC Form 4 filed by Karlin DanForm 4Open-market sale
- Mar 14, 2023DFTXSEC Form 4: Karlin Dan was granted 125,000 shares, increasing direct ownership by 48% to 385,505 unitsForm 4Grant or award
- Mar 1, 2023-$12.6KDFTXSEC Form 4: Karlin Dan sold $12,555 worth of shares (3,577 units at $3.51), decreasing direct ownership by 1% to 260,505 units (tax withholding)Form 4Open-market sale
- Dec 21, 2022-$3,258DFTXSEC Form 4: Karlin Dan sold $3,258 worth of shares (1,211 units at $2.69), decreasing direct ownership by 0.46% to 264,082 units (tax withholding)Form 4Open-market sale
- Oct 27, 2022-$3,452DFTXSEC Form 4: Karlin Dan sold $3,452 worth of shares (1,185 units at $2.91), decreasing direct ownership by 0.44% to 265,293 units to cover withholding taxForm 4Open-market sale
- Sep 27, 2022-$6,870DFTXSEC Form 4: Karlin Dan sold $6,870 worth of shares (1,205 units at $5.70), decreasing direct ownership by 0.45% to 266,478 units (for withholding tax)Form 4Open-market sale
- Aug 31, 2022-$14.1KDFTXSEC Form 4: Karlin Dan sold $14,051 worth of shares (1,204 units at $11.67), decreasing direct ownership by 0.45% to 267,683 units (tax withholding)Form 4Open-market sale
- Jul 27, 2022-$12.6KDFTXSEC Form 4: Karlin Dan sold $12,570 worth of shares (18,217 units at $0.69), decreasing direct ownership by 0.45% to 4,033,264 units (withholding tax)Form 4Open-market sale
- Jun 27, 2022-$18.4KDFTXSEC Form 4: Karlin Dan sold $18,367 worth of shares (26,238 units at $0.70), decreasing direct ownership by 0.64% to 4,051,481 units to satisfy withholding taxForm 4Open-market sale
- May 27, 2022-$7,835DFTXSEC Form 4: Karlin Dan sold $7,835 worth of Subordinate Voting Shares (9,555 units at $0.82), decreasing direct ownership by 0.23% to 4,077,719 units (withholding tax)Form 4Open-market sale
- May 25, 2022-$6,346DFTXSEC Form 4: Karlin Dan sold $6,346 worth of Subordinate Voting Shares (8,242 units at $0.77), decreasing direct ownership by 0.20% to 4,087,274 units (tax withholding)Form 4Open-market sale
- Apr 26, 2022DFTXSEC Form 4: Karlin Dan covered exercise/tax liability with 13,038 units of Subordinate Voting Shares, decreasing direct ownership by 0.32% to 4,095,516 units to satisfy withholding taxForm 4Shares withheld for taxes or exercise price
- Mar 28, 2022DFTXSEC Form 4: Karlin Dan covered exercise/tax liability with 10,203 units of Subordinate Voting Shares, decreasing direct ownership by 0.25% to 4,108,554 units to satisfy tax liabilityForm 4Shares withheld for taxes or exercise price
- Mar 24, 2022DFTXSEC Form 4: Karlin Dan was granted 950,000 units of Subordinate Voting Shares, increasing direct ownership by 30% to 4,118,757 unitsForm 4Grant or award
- Feb 26, 2022DFTXSEC Form 4: Karlin Dan covered exercise/tax liability with 118,143 units of Subordinate Voting Shares, decreasing direct ownership by 4% to 3,168,757 units (tax withholding)Form 4Shares withheld for taxes or exercise price
- Jan 1, 2022DFTXSEC Form 3: New insider Karlin Dan claimed ownership of 3,286,900 units of Subordinate Voting SharesForm 3New insider
Also sits on boards with
Officers and directors who share two or more companies with Daniel Karlin.
Compare Daniel Karlin with
- Daniel Karlin vs Mark Sullivan2 shared
- Daniel Karlin vs Robert Barrow1 shared
- Daniel Karlin vs Matthew T. Wiley1 shared
- Daniel Karlin vs Brandi Roberts1 shared
- Daniel Karlin vs Carol A Vallone1 shared
- Daniel Karlin vs Andreas Krebs1 shared
Other insiders at the same companies
- Robert BarrowDFTX
- Matthew T. WileyDFTX
- Brandi RobertsDFTX
- Carol A ValloneDFTX
- Andreas KrebsDFTX
- David W GryskaDFTX
- Roger CrystalDFTX
- Roger AdsettDFTX
- Suzanne Louise BruhnDFTX
- Carrie LiaoDFTX
Questions about Daniel Karlin
- What is Daniel Karlin's role at Definium Therapeutics, Inc.?
- Daniel Karlin reports to the SEC as chief Medical Officer and director at Definium Therapeutics, Inc. (DFTX), according to the latest filing on September 30, 2026. Daniel Karlin has also filed as officer at Mind Medicine (MindMed) Inc. (MNMD).
- How many shares does Daniel Karlin own?
- After the latest filing that states it, Daniel Karlin directly owned 792,846 shares of Definium Therapeutics, Inc. (DFTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Daniel Karlin bought or sold stock recently?
- The most recent open-market sale was on September 25, 2026: sold 10,853 shares of Definium Therapeutics, Inc. (DFTX) for $397K at an average of $36.57.
- How do I get alerts when Daniel Karlin files?
- Follow Daniel Karlin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Daniel Karlin filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Daniel Karlin (SEC CIK 0001897618). Totals count each trade once, skipping amendments whose original is on file, from Jan 11, 2022 on. View on SEC EDGAR · Get this as JSON